Life Science Nation

LSN is a Boston-based firm founded in 2012, driven by CEO Dennis Ford’s vision of expediting the process of scientific development, from discovery through distribution, by providing early stage life science companies with a Match.com-like sourcing platform. This platform enables executives to find investors who are a fit for their Biotech, Medtech, Diagnostic and Healthcare IT company. LSN provides 2 proprietary data platforms, the Investor Platform and Company Platform. The Investor Platform represents an ongoing dialogue with over 5,000 investors around the globe and is the only life science-specific investor platform available to executives raising capital. The Company Platform tracks over 40,000+ emerging Biotech, Medtech, Diagnostics and Healthcare IT companies, which by their ephemeral nature are challenging to find and track. LSN is a successful organizer of the Redefining Early Stage Investments (RESI) Conference series, held 5 times a year across North America. RESI brings together a global gathering of early-stage life science entrepreneurs and investors, helping them build valuable connections for investment, partnerships, and more. In addition, LSN owns and operates Boston Innovation Capital (BIC), an investment advisory firm that plans and executes global fundraising campaigns for early stage firms raising capital in the range of USD 10-50 million.

show less